Cargando…
Neuroretinal Biomarkers for Schizophrenia Spectrum Disorders
PURPOSE: We evaluated the patient-control differences and predictive value of the retina as potential biomarkers for schizophrenia. METHODS: The institutional study included both eyes of 58 schizophrenia spectrum disorder (SSD) patients (age 37.2 ± 12.3 years) and 35 controls (age 41.1 ± 15.2 years)...
Autores principales: | Asanad, Samuel, O'Neill, Hugh, Addis, Hampton, Chen, Shuo, Wang, Jingtao, Goldwaser, Eric, Kochunov, Peter, Hong, L. Elliot, Saeedi, Osamah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083086/ https://www.ncbi.nlm.nih.gov/pubmed/34004009 http://dx.doi.org/10.1167/tvst.10.4.29 |
Ejemplares similares
-
OCTA in neurodegenerative optic neuropathies: emerging biomarkers at
the eye–brain interface
por: Asanad, Samuel, et al.
Publicado: (2020) -
White matter in prolonged glucocorticoid response to psychological stress in schizophrenia
por: Goldwaser, Eric L., et al.
Publicado: (2021) -
Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
por: Chiappelli, Joshua, et al.
Publicado: (2020) -
Neuroretinitis Optica
Publicado: (1884) -
Toxoplasma Neuroretinitis
por: Hsu, Christine, et al.
Publicado: (2022)